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ABSTRACT
￿
The location of the epitopes for monoclonal antibodies against chicken type IV
and type V collagens were directly determined in the electron microscope after rotary
shadowing of antibody/collagen mixtures . Three monoclonal antibodies against type IV col-
lagen were examined, each one of which was previously demonstrated to be specific for only
one of the three pepsin-resistant fragments of the molecule . The three native fragments were
designated (F1)2 F2, F3, and 7S, and the antibodies that specifically recognize each fragment
were called, respectively, IA8, 111312, and ID2 . By electron microscopy, monoclonal antibody
IA8 recognized an epitope located in the center of fragment (F1)2F2 and in tetramers of type
IV Collagen at a distance of 288 nm from the 7S domain, the region of overlap of four type IV
molecules . Monoclonal antibody 111312, in contrast, recognized an epitope located only 73 nm
from the 7S domain . This result therefore provides direct visual evidence that the F3 fragment
is located closest to the 7S domain and the order of the fragments must be 7S-F3-(Fl)2 F2 . The
epitope for antibody ID2 was located in the overlap region of the 7S domain, and often
several antibody molecules were observed binding to a single 7S domain . The high frequency
with which antibody molecules were observed to bind to fragments of type IV collagen
suggests that there is a single population of type IV molecules of chain organization
[al(IV)] 2a2(IV), and that four identical molecules must form a tetramer that is joined in an
antiparallel manner at the 7S domain .
The monoclonal antibodies against type V Collagen, called AB12 and DH2, were both found
to recognize epitopes close to one another, the epitopes being located 45-48 nm from one
end of the type V collagen molecule . The significance of this result still remains uncertain, but
suggests that this site is probably highly immunoreactive . It may also be related to the specific
cleavage site of type V collagen by selected metalloproteinases and by a-thrombin . This
cleavage site is also known to be located close to one end of the type V molecule .
Monoclonal antibodies of high affinity prepared against the
different types of collagen potentially have several advantages
when compared to conventionally prepared polyclonal anti-
bodies (reviewed in reference 1) . Several groups have now
described the preparation of monoclonal antibodies of high
specificity for each of the five major collagen types (2-9) . In
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previous experiments, we have prepared monoclonal antibod-
ies that specifically recognized epitopes present in native
molecules of chicken type IV collagen (10, 11) and type V
collagen (12) . These antibodies are now being used as reagents
to investigate the macromolecular organization and function
ofthese collagens in several tissues including lens capsule (13),
1637cornea (14), and skeletal muscle (15) . For type IV collagen,
three monoclonal antibodies were selected, each one recog-
nizing an epitope present in only one of the three pepsin-
resistant fragments ofthe molecule (10, 11) . Previously, these
three fragments were designated (F1)2F2, F3, and 7S (16, 17) .
In the present series of experiments, the direct localization of
the epitope for each of the three monoclonal antibodies was
determined in the electron microscope after rotary shadowing .
By examining type IV collagen molecules that contained both
the intact triple helical domain and the cross-linking site
between four type IV molecules called 7S (18, 19), it proved
possible to obtain an "immunomap" of the location of the
three pepsin-resistant fragments. These results greatly
strengthen earlier conclusions that the order of the pepsin-
resistant domains ofchickentype IV collagen is 7S-F3-(F1)ZF2
(11, 17), and that in tissues there is a single type IV collagen
molecule of chain organization [aI(IV)] Za2(IV) (16, 20). For
type V collagen, the two monoclonal antibodies thatwe have
previously characterized (12) were found to "immunomap"
to epitopes close to one another and located 45-48 nm from
one end ofthe molecule .
MATERIALS AND METHODS
Isolation and Purification of Collagens :
￿
Types IV and V colla-
gens were isolated after limited pepsin digestion of chicken gizzards and
fractionated by differential salt precipitation first in acidic and then in neutral
conditions (16). Further purification of the fragment (Fl)2F2 was achieved by
CM-cellulose chromatography ofthe typeIVcollagen fraction in nondenaturing
conditions (16), followed by molecular sieve chromatography, (Bio-Gel A-15m
[Bio-Rad Laboratories, Richmond, CA]) at 4°C (10). Isolation ofa high molec-
ular weight fraction oftype IV fragments enriched in 7S and F3 domains was
achieved by molecular sieve chromatography (Bio-Gel A-15m) after denatura-
tion of the sample at 45°C for 30 min (16, 17) . To isolate a type IV collagen
preparation in which 7S domains with triple-helical arms the full length of360
nm could be observed after rotary shadowing, we obtained gizzards from
chickens made lathyritic by providing ß-aminopropionitrile (0.025%) in the
drinking water for 4-5 wk . After initial washings ofgizzard homogenates with
I M NaCl, pH 7.4, followed by 0 .5 M HAc, limited pepsin digestion was
performed once at a concentration of 100,ug/ml in 0 .5M HAc, and the pepsin
inactivated at pH 8 .0, as described previously (16). To separate type IV and
type V collagens from interstitial collagens, we collected the precipitate during
differential salt precipitation between 0.65 M NaCl, 0.5 M HAc and 1 .2 M
NaCI, 0.5 M HAc . Type IV collagen was then separated from type V collagen
and any remaining interstitial collagens by CM-cellulose chromatography in
nondenaturing conditions (16), desalted by dialysis against 0. I M HAc and
lyophilized .
Preparation of Hybridomas and Production of Monoclonal
Antibodies :
￿
The preparation and characterization ofthe five hybridomas
used in this publication have been described in detail elsewhere : antibody IA8
against the (Fl)2F2 fragment of type IV collagen in reference 10, antibodies
ID2and111112 against the 7S and F3 fragments, respectively, oftype IV collagen
in reference 11, and antibodies DH2 and AB12 against type V collagen in
reference 12 . In all cases, female SJL/3 mice were immunized with the appro-
priate collagen, and fusion of splenocytes was performed with NS 1 myeloma
cells from which hybridomas of the desired characteristics were subsequently
selected (1) . All five antibodies were of the IgG class (10-12) .
Purification of Monoclonal Antibodies :
￿
To prepare and purify
large amounts of antibody, we injected 5-10-x-106 hybridoma cells into the
peritoneal cavity ofathymic nude mice (nu/nu). After 2-3 wk, ascites fluid was
harvested, briefly centrifuged, and protease inhibitors added to the supernatant.
Immunoglobulins were precipitated from the supernatant with ammonium
sulfate (50% ofsaturation, 4°C). After standing for 1 h, the precipitateobtained
by centrifugation (48,000 g, 30 min, 4°C) was redissolved in 0.01 M phosphate
buffered saline (PBS) (pH 7.2) and a second ammonium sulfate precipitate
(50% of saturation) performed. Immunoglobulins were dissolved in 0.01 M
PBS, and dialyzed extensively against PBS before being stored at 4°C. Each
immunoglobulin preparation was characterizedby SDS PAGE using a 5-10%
gradient slab gel withoutthe inclusion ofurea (21) . Further purification ofeach
antibody was performed by affinity chromatography using a Sepharose-411
column towhich the appropriate collagen hadbeen coupled. For antibody IA8,
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an affinity column of unfractionated type IV was used, whereas for antibodies
ID2 and IIB12 an affinity column was prepared with a high molecular weight
fraction oftype IV collagen isolated after molecularsievechromatography(Bio-
Gel A-15m) and enriched in 7S and F3 domains (11, 17) . For purification of
antibodiesDH2 andAB12, we prepared a type V collagen affinity column . For
each affinity column Sepharose-411 (Pharmacia Fine Chemicals, Piscataway,
NJ) was firstactivated withCNBr asdescribed byFurthmayr(22). The activated
gel was mixed with an equal volume of collagen solution (5 mg/ml, dissolved
in 0 .1 M calcium acetate, pH 8.8) and shaken for 24 h at 4°C. The gel was
washed once with 0.1 M calcium acetate, pH 8 .8, and then resuspended in an
equal volume of 0.2 M calcium acetate containing 1 % ethanolamine, pH 8 .8,
and shaken for 6 h at 4°C to block unreacted sites. Subsequently, the gel was
washed with 0 .1 M calcium acetate, pH 8 .0, followed by l M HAc, 0.15 M
NaCl until a pH of3 .0 was reached . The gel was then washed with 0. l M Tris
to a pH of greater than 7.0. Finally, the gel was washed with 0.1 M PBS, pH
7 .4, containing 0.02% sodium azide and stored at 4°C . The efficiency of
coupling was always >50% . Affinity columns (0.5 x 12 cm) were prepared for
each gel, and ammonium sulfateprecipitates from ascites fluidwere redissolved
in PBS and passed over the appropriate column. Material that was retained on
the column was eluted with 3 M KSCN, 0.05 M PBS, pH 6.0, dialyzed
immediately against PBS and concentrated by ultrafiltration . Protein assays
wereperformed by the method ofLowry(23), and ELISAs for antibody activity
were carried out with a Hybridoma Screening Kit (Bethesda Research Labora-
tories, Gaithersburg, MD), as described previously (10) .
Fig. 1 shows the purification of monoclonal antibody DH2 against type V
collagen and was representative ofthe purifications achieved . Two fight chains
were present in the ammonium sulfate precipitate of the immunoglobulins
from ascites fluid (Fig. I, lanes 1 and 2) . However, only one of these chains
was present in the immunoglobulin fraction which was not retained on the
typeV affinity column (Fig. 1, lanes 3 and 4). This chain is therefore derived
from the NS1 myeloma that can synthesize its own light chains and will
incorporate them into intact immunoglobulin molecules(24) . Both light chains
were present in the retentate from the column (Fig. 1, lanes 5 and 6), but the
faster migrating light chain from the splenocyte predominated. The immuno-
globulin fractions purified by this procedure therefore contain some hybrid
molecules in which one light chain is derived from the NS 1 myeloma and one
light chain is derived from the splenocyte . Such hybrid antibody molecules
were observed for all five monoclonal antibodies that were purified, although
the relative proportions ofthe two light chains varied .
Rotary Shadowing of Collagen/Antibody Binding :
￿
The pro-
cedures used for rotary shadowing with platinum and subsequent electron
FIGURE 1
￿
SDS PAGE (5-10% gradient gel) of monoclonal antibody
DH2 before and after chromatography on a type V affinity column .
(Lanes 1 and 2) The ammonium sulfate precipitate from ascites
fluid. (Lanes 3 and 4) The eluate from the column . (Lanes 5 and 6)
The retentate that was subsequently eluted with 3 M KSCN, pH
6.0 .microscopy andphotography were as described previously (19), except that a
mixture of the collagen and antibody solutions were first dialyzed overnight
against 0.2 M ammonium bicarbonate before spraying. Lengths of collagen
molecules and the location of antibody binding sites were measured using a
Science Accessories Graf Pen 3 sonic digitizer (resolution 0.1 mm) interfaced
with a Hewlett Packard 9825A programable calculator. As a control for
nonspecific binding ofantibody molecules during rotary shadowing, both type
IV spiders and typeV were shadowed in the presence ofan IgGI monoclonal
antibody 317 against human plasma fibronectin (25). No specific localization
of the antifibronectin antibody to either type IV or typeV collagen molecules
was observed.
RESULTS
Localization of the Epitopes for Monoclonal
Antibodies to Type IVCollagens
ANTIBODY IA8:
￿
Fig. 2 shows an electron micrograph
after rotary shadowing of antibody IA8 interacting with a
highly purified preparation of the fragment (F1) 2F2. The
antibody was observed to bind to the center of all (F1)2F2
fragments . The length of (F1)2F2 was measured to be 149 ±
7 nm, this value comparing closely to our previous length of
147 nm for this fragment (17) . For mixtures of (F1)2F2
fragments and antibody IA8, we found that 91% (149 frag-
ments examined) possessed an antibody molecule located in
the center; therefore, we propose that is the location of the
epitope .
We then used the antibody IA8 to locate its epitope within
larger fragments oftype IV collagen in which the 7S domain
and the full length of the triple helix were present . Fig . 3
shows rotary shadowingperformed with a mixture ofantibody
IA8 and a type IV collagen preparation isolated from lathyritic
chicken gizzards with pepsin digestion performed at a concen-
tration ofonly 100 Ag/ml .We observed numerous 7S domains
(Fig. 3, arrows) from which one or more arms of collagen
triple helix extended . In each of the longer arms the binding
ofan antibody molecule was observed to occur near the end.
No evidence was found for specific binding of antibody
molecules elsewhere along the collagen triple helix or at the
7S domain . For one of the 7S domains shown in Fig. 3 three
full length arms oftype IV collagen were observed, each one
of which possessed a IA8 antibody bound to the same site .
Free (F1)2F2 fragments were also often observed with an
antibody molecule binding to the center of the fragment (Fig.
3) . Measurement of the length of the longer arms from the
overlap of 7S gave an average value of 358 ± 12 nm, which
agrees well with earlier estimates of 355-358 nm for this
length inhuman and mouse tumortype IV collagen molecules
(19, 26) . Of the 85 arms examined, 65 possessed a IA8
antibody molecule located at the same site 288 ± 11 nm from
the overlap of the 7S domain . For the (F1)2F2 fragment to be
located farthest from the 7S domain, then the difference in
length between the binding site of the antibody and the full
length of the triple helix (i.e ., 358 - 288 nrn or 70 nm) should
correspond closely to one half of the length of (F1)2F2 (74.5
nm) . This occurs and provides direct evidence for the location
of(F1)2F2 along the major triple helical domain .
ANTIBODY 1132 :
￿
Fig . 4 shows the binding of antibody
ID2 to the 7S domains of several type IV collagen molecules
isolated from lathyritic chicken gizzard after a very limited
pepsin digestion . In all cases, several ID2 molecules were
observed binding to one 7S domain that has become obscured
by the antibody. The inset of Fig . 4 shows a type IV collagen
"spider" with four intact arms in which the binding of two or
possibly three antibody molecules to the 7S domain can be
recognized. No other specific binding of the antibody could
be recognized along the collagen triple helix. Of 38 of the 7S
FIGURE 2
￿
Electron micrograph after rotary shadowing ofantibody IA8 interacting with the fragment of type IV collagen designated
(F1) 2F2 . Theantibody (40lAg/ml) andthe antigen (80 pg/ml) were mixed together and dialyzed overnight against 0 .2Mammonium
bicarbonate before being sprayed onto freshly cleaved mica and shadowed with platinum . Bar, 100 nm . x 144,000 .
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1639FIGURE 3
￿
Electron micrograph after rotary shadowing of antibody IA8 interacting with a type IV collagen preparation isolated
from lathyritic chicken gizzard by very limited pepsin digestion. The antibody and antigen were mixed together at concentrations
of 40,ug/ml and 80 I<g/ml, respectively . Note the presence of 7S domains (arrows) from which two or three full length collagenous
arms extend and to which the binding of antibody IA8 can be observed at the expected location near the end . Also, note the
occasional fragment of (F1) 2F2 with binding of IA8 at the center . Bar, 100 nm . x 116,000 .
FIGURE 4
￿
Electron micrograph after rotary shadowing of antibody ID2 interacting with a type IV collagen preparation isolated
from lathyritic chicken gizzard by very limited pepsin digestion . The antibody and antigen concentrations were both 50 ug/ml .
Note that several ID2 molecules are binding to each 7S domain . Bar, 100 nm, x 87,000 . (Inset) A spider of four type IV collagen
molecules in which binding of two or possibly three molecules of ID2 to the 7S domain can be clearly observed . Bar, 100 nm .
x 150,000 .
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molecule binding to this site .
ANTIBODY IIB 12 :
￿
In Fig . 5A a single IIB12 antibody
molecule is observed binding to one of the four arms of a
type IV spider extending from 7S, whereas in Fig. 513 three
antibodiesare present, all apparentlybinding equidistant from
the 7S domain. One of these latter antibodies may be cross-
linking two of the arms extended from 7S . These results were
obtained using a very low ratio ofantibody to antigen (30 Kg/
ml antibody mixed with 50 rig/ml antigen), but with a higher
ratio of antibody to antigen (50 tLg/ml and 50 A.g/ml) addi-
tional associations of antibody molecules to the type IV
spiders were observed . Fig. 5C shows a histiogram of the
distribution of antibody molecules along each spider . The
results clearly show that specific binding and not random
apparent associations occurred only in the region close to 7S,
and it was estimated that the location of the epitope for IIB 12
is 73 ± 8 nm (72 measurements) from the overlap of 7S. For
this calculation only those antibodies that bound between 60
and 89 nm from the overlap of 7S (62% of all antibody
binding) were included in the calculation .
These results on the immunolocalization ofthe three mon-
oclonal antibodies to type IV collagen have made it possible
to construct an "immunomap" of a spider as illustrated in
Fig . 6 . Four identical type IV molecules are considered to
overlap in an antiparallel manner at the 7S domain, and as
many as four epitopes will therefore be available for binding
ofID2 at this site . Previous data suggested that the F3 domain
is closest to 7S (11, 17), and binding of 111312 occurs within
the proposed location of this fragment . Finally, the rotary
shadowing observations clearly show that (FI)ZF2 is located
farthest from 7S . In the diagram the noncollagenous carboxyl
termini (27), called NGI (26), have also been included,
although in our preparations these are cleaved during pepsin
digestion to prepare the spiders .
Localization of the Epitopes for Monoclonal
Antibodies to Type VCollagen
ANTIBODY D H2 :
￿
In Fig . 7 three molecules of type V
collagen are shown with antibody DH2 bound to the same
FIGURE 5 (A and B) Electron micrographs after rotary shadowing
of antibody IIB12 interacting with type IV collagen spiders isolated
from lathyritic chicken gizzard . (C Histiogram of the distribution of
the association of antibody 111312 to type IV collagen spiders. The
concentration of antigen was fixed at 50 jug/ml and the concentra-
tions of antibody were 30,ug/ml in A and B and 50 pg/ml in C. Note
in A and B that specific binding apparently occurs only at a single
site on each type IV molecule present in the spiders . However, the
histiogram (C) illustrates that at a higher antibody concentration
some nonspecific associations also apparently occur along the type
IV collagen molecules . Bar, 100 nm . x 150,000 .
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1641site located close to one end ofeach molecule.Of91 molecules
examined 56 (62%) were found to possess an antibody located
at a distance of45 ± 8 nm from one end of the molecule . No
other specific binding site could be identified . We therefore
propose that this site is the location of the epitope for DH2 .
The average length ofthe typeV collagen molecules examined
was 296 ± 8 nm (31 measurements), this comparing closely
to the length of interstitial collagens .
ANT IBODY AB12 :
￿
Fig. 8 shows that antibody AB 12 ap-
peared to bind to type V collagen at the same site as DH2,
which was measured to be located 48 ± 5 nm from one end
of the molecule. However, of 121 molecules examined only
54 (45%) of the molecules possessed an AB12 antibody bind-
FIGURE 8 Electron micrograph
after rotary shadowing of anti-
body AB12 interacting with type
V collagen . Antibody and antigens
were both at concentrations of
50 ug/ml . Arrows show the anti-
body binding to four molecules at
the same site . Bar, 100 nm .
x 145,000 .
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FIGURE 6
￿
Immunomap of the location of the epitopes for mono-
clonal antibodies 111312, ID2, and IA8 within a spider of type IV
collagen . Note that four identical type IV molecules overlap at the
7S domain, and that the location of the epitopes for the three
antibodies demonstrates that the three pepsin-resistant fragments
are in the order proposed earlier (11, 17). NC-1 domains (26) have
also been included in the model, although in the collagen prepa-
rations used in the present experiments these were cleaved away
during pepsin digestion .
ing at this site . The average length of the type V collagen
molecules examined in this group was 292 ± 8 nm (42
molecules measured) .
These results were surprising as in previous experiments
ELISAs performed with a mixture of AB12 and DH2 gave
partially additive results when both antibodies were present
together as compared to each antibody being present sepa-
rately (12) . Experiments were therefore performed in which
rotary shadowing was performed with a mixture ofAB 12 and
DH2 . Fig. 9 shows type V molecules with both antibodies
FIGURE 7
￿
Electron micrograph after rotary shadowing of antibody
DH2 interacting with type V collagen . Antibody and antigens were
both at concentrations of 50 wg/ml . Note that the antibody is located
at the same site for all three molecules . Bar, 100 nm . x 116,000.FIGURE 9
￿
Composite electron micrographs of rotary shadowing of
type V collagen in the presence of a mixture of antibody DH2 and
AB12 . The antibodies AB12 and DH2 were first mixed together in
a 2 :1 proportion, and then 50 Ag/ml of this solution was mixed with
50 kg/ml of the antigen before rotary shadowing . Note the presence
in each molecule (arrows) of two antibodies binding to the same
site . Bar, 100 nm . x 130,000 .
now located at the same site. Although the numbers of such
molecules was small (30 of 629 molecules examined), such
pairs of antibody molecules were never observed after rotary
shadowing when either AB 12 or DH2 were present separately.
No binding of antibody 317 against human fibronectin could
be observed at this site and, as a further control, rotary
shadowing of type V molecules was also performed in the
presence of antibody IIB 12 (against the F3 fragment of type
IV) . No specific binding of this latter antibody could be
observed, showing that there must be a unique interaction
between both DH2 and AB 12 at the same location along the
type V molecule . We therefore conclude that the epitopes for
DH2 and AB 12 are very close to each other, and appear to
map at the same site .
DISCUSSION
The present results show that it is possible to select mono-
clonal antibodies that recognize a single epitope in a collagen
molecule with a sufficiently strong affinity that the interaction
can be visualized in the electron microscope after rotary
shadowing. Success with this approach has already been
achieved with monoclonal antibodies to human type IV col-
lagen (28, 29), and with a polyclonal antibody to bovine 7S
(30). Rotary shadowing observations with one of the mono-
clonal antibodies to type IV collagen has shown that the
epitope for this antibody is located 60 nm from the end of
the overlap of 7S (28) . However, human type IV collagen is
not cleaved by pepsin into three native fragments in the same
manner as the chicken, and so the type ofimmunomapping
described in this paper has therefore not been possible .
The results in this papernow firmly establish that the order
of the pepsin-resistant fragments of chicken type IV collagen
is 7S-F3-(F1)2F2, as suggested by earlier experiments (11, 17) .
In addition, the results provide further support to earlier
proposals that there is a single type IV collagen molecule of
chain organization [aI(IV)] Za2(IV) (16, 20) . For chicken type
IV collagen, this conclusion was previously based on extensive
biochemical analysis of the fragment (FI)ZF2 for which after
denaturation F1 and F2 were consistently isolated in a 2 :1
proportion (16, 20) . In this paper, we have observed that
>90% of the (Fl)2F2 fragments are recognized by IA8,
strongly suggesting that there is a homogeneous population
of these fragments . In addition, the location of this fragment
within the type IV collagen molecule is now clearly demon-
strated .
Previous studies have established for mouse procollagen
that the carboxyl termini of four type IV molecules that form
the spider are located farthest from 7S (27) at a region called
NC-1 (26) . Four identical amino termini must therefore over-
lap to form the 7S domain . This conclusion is supported by
the present observation ofseveral ID2 molecules binding to a
single 7S domain (Fig . 4) . Previously, it has been shown that
the additional cysteine residues of the aI(IV) chain which are
not present in 7S are located towards the amino end of the
major collagen triple helix (20, 31). The location of these
residues presumably corresponds to the location of the inter-
chain disulfide bridges present in F3, although at present there
is no direct evidence to confirm this. A more direct demon-
stration of the location of the interchain disulfide bridges
along the major triple helix of the type IV molecule has
recently been achieved with a monoclonal antibody against
native human type IV collagen (29) . Rotary shadowing obser-
vations have shown that this antibody recognizes an epitope
located 57 nm from the overlap region of 7S . The antibody
also recognizes a small native fragment generated by CNBr
cleavage of type IV collagen that contains aI(IV) C1315 and
in which interchain disulfide bridges are present (32).
The present results now provide direct evidence that each
monoclonal antibody against type IV collagen recognizes a
single epitope present at different locations along the collagen
molecule . It may be possible now to use these antibody
molecules to perform electron microscopic immunolocaliza-
tion of the different regions of the type IV molecule within
basement membrane structure . Previous experiments with
polyclonal antibodies against type IV collagen and electron
microscopic immunolocalization have suggested that type IV
collagen is present either in the lamina densa (33) or through-
out the basement membrane of the glomerulus (34-36) . It
may now be possible to use our monoclonal antibodies for
electron microscopic studies and show the location ofthe 7S,
F3, and (F1)2F2 domains in the glomerular basement mem-
brane. With the two monoclonal antibodies to type V colla-
gen, electron microscopic immunolocalization may also pro-
vide further information with regard to the function of this
collagen . The present information from our light microscopic
studies (12) and from electron microscopic immunolocaliza-
tion with a polyclonal antibody to typeV collagen (37) suggest
that this collagen is present in interstitial connective tissue
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larger fibers of type I collagen (Fitch, J . M ., J . Gross, R .
Mayne,B. Johnson-Wint, and T. F. Linsenmayer, 1984, Proc.
Nat '1Acad . Sci. USA, in press).
The significance of the localization of the epitopes for the
two monoclonal antibodies to type V collagen to the same
site along the type V molecule is at present unclear . It may
be that there is a discrete region along the type V molecule
that is highly immunogenic and gives rise to antibodies of
sufficient affinity to survive our screening procedures. The
site is located 45-48 nm from one end of the molecule or an
approximated distance of 15% of the total length of the
collagen molecule . This location appearsto correspond closely
in distance to the site of cleavage of type V collagen either
with metalloproteinases that degrade native type V collagen
(38-40) or with a-thrombin (41) . However, we do not at
present know if the epitopes and the cleavage site are both
located at the same end of the molecule, and are either at, or
very close to, the same site . To demonstrate this directly, it
may be possible to inhibit protease cleavage oftype V collagen
with one or both of our antibodies. Similar experiments have
recently been successfully performed with a monoclonal an-
tibody against the amino terminal cleavage site of type I
procollagen in which it was shown that the antibody would
inhibit the activity of procollagen N-proteinase (42) .
Our present method ofimmunomapping with monoclonal
antibodies may also provide important structural information
for other poorly characterized collagen molecules such as the
minor cartilage collagens of high and low molecular weight
which so far have only been isolated as pepsin-resistant frag-
ments (21) . It may also be possible to use monoclonal anti-
bodies combined with rotary shadowing to investigate the
macromolecular organization ofcollagen molecules that form
complex structures too large to be analyzed directly by bio-
chemical methods.
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